精氨酸衍生物的谷氨介导的神经保护作用
Nobuko Matsumura1, Koji Aoyama1
1Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan.
International journal of molecular sciences
|September 9, 2023
概括
咖啡因和偏素等纯氨酸衍生物可能通过增加关键抗氧化剂谷氨来保护大脑细胞. 这为预防或延迟神经退行性疾病 (如阿尔茨海默氏症和帕金森病) 提供了潜在的新策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- purin衍生物,包括咖啡因和尿酸 (UA),表现出神经保护性质.
- 流行病学研究将咖啡因摄入量和血清尿酸盐水平与阿尔茨海默病 (AD) 和帕金森病 (PD) 的风险降低联系起来.
- 已知的机制包括腺A2A受体对抗性 (咖啡因) 和抗氧化活性 (UA).
研究的目的:
- 审查氨酸 (GSH) 介导的 purin衍生物的神经保护作用.
- 突出帕拉丁作为一种具有神经保护潜力的纯氨酸衍生物.
- 探索通过GSH枯竭的特征的神经退行性疾病的治疗应用.
主要方法:
- 文献综述总结了关于纯素衍生物和神经保护的现有研究.
- 专注于激发性氨基酸载体蛋白1 (EAAC1) 在调解囊蛋白吸收中的作用.
- purin衍生物对神经元谷氨 (GSH) 水平的影响分析.
主要成果:
- 帕拉丁,类似于咖啡因和UA,表现出神经保护作用.
- 氨酸衍生物通过EAAC1.1增强神经元的氨酸吸收.
- 这一过程导致细胞内神经质 (GSH) 水平增加.
结论:
- 谷氨酸耗尽是神经退行性疾病的标志,如AD和PD.
- 纯氨酸衍生物可以提高神经元的GSH水平,提供一种保护机制.
- 精氨酸衍生物的使用代表了神经退行性疾病的潜在治疗策略.
相关概念视频
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
253
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
253
Biosynthesis of Nucleic Acids
75
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
75
Anticholinesterase Agents: Poisoning and Treatment
918
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
918
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Antiepileptic Drugs: Glutamate Antagonists
418
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
418
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
715
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
715


